Double-Dose stem cell therapy shows promise for tough childhood cancer
NCT ID NCT02605421
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving two rounds of very strong chemotherapy, each followed by a stem cell transplant using the patient's own cells, can help children and young adults with high-risk neuroblastoma stay cancer-free longer. Participants must have already completed initial chemotherapy and have enough stored stem cells. The goal is to improve survival without the cancer coming back.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Masonic Cancer Center, University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a shorter chemo combo tame High-Risk neuroblastoma?
- Can a radioactive 'Smart Bomb' take down resistant childhood cancers?
- Can AI read tumor slides to outsmart childhood cancer?
- Can a radioated molecule shrink untreatable neuroblastoma?
- Slowing down immunotherapy infusion may reduce pain in children with Tough-to-Treat neuroblastoma